The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier B.V.
Abstract
This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options. © 2023 The Author(s)
Description
Keywords
Chemoembolisation, Hepatocellular carcinoma, Immunotherapy, Liver transplantation, Radioembolisation, Carcinoma, hepatocellular, Expert testimony, Gastrointestinal neoplasms, Humans, Liver neoplasms, Antineoplastic agent, Ablation therapy, Cancer diagnosis, Cancer patient, Cancer radiotherapy, Cancer screening, Cancer staging, Cancer surgery, Cancer therapy, Chemoembolization, Consensus development, Hepatectomy, Human, Interdisciplinary research, Liver cell carcinoma, Liver cirrhosis, Publication, Radioembolization, Review, Spain, Systemic therapy, Terminal cancer, Expert witness, Gastrointestinal tumor, Liver tumor